Internal Medicine, Endocrinology, Diabetes, & Metabolism · Lexington, KY
NPI
1255493342
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1775 Alysheba Way, Suite 50
Lexington, KY, 40509
Phone (859) 639-1210
Groups this clinician bills Medicare through
Medicare paid, 2024
$66K
1,808 services
Medicare patients, 2024
532
Average age 71
Drug cost, 2024
$4.1M
9,566 prescriptions
Company payments, 2025
$459
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lyle C Myers was code 99213 (office e&m - established), 496 times for 370 patients. In total Lyle C Myers billed 1,808 services in 13 codes, and Medicare paid $66K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-02-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 496 | 370 | $60.25 | $30K |
| 82947 Clinical Chemistry | Office | 364 | 271 | $3.80 | $1,383 |
| 83036 Blood Count | Office | 349 | 258 | $9.39 | $3,278 |
| 99214 Office E&M - Established | Office | 252 | 214 | $79.24 | $20K |
| 36415 Venipuncture Blood Collection | Office | 174 | 159 | $8.65 | $1,505 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 39 | 38 | $12.29 | $479 |
| 99204 Office E&M - New | Office | 39 | 39 | $113.31 | $4,419 |
| 95251 Test - Miscellaneous | Office | 38 | 35 | $23.40 | $889 |
| 99203 Office E&M - New | Office | 31 | 31 | $72.38 | $2,244 |
| 76536 Ultrasound - Nonspecific | Office | 21 | 21 | $75.91 | $1,594 |
By year: 2022 $66K for 2,034 services; 2023 $72K for 2,267 services; 2024 $66K for 1,808 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82947 Clinical Chemistry | 364 | 271 | $3.80 | $1,383 |
| 83036 Blood Count | 349 | 258 | $9.39 | $3,278 |
| 36415 Venipuncture Blood Collection | 174 | 159 | $8.65 | $1,505 |
Medicare prescription drug claims, 2024
In 2024, the drug Lyle C Myers prescribed most often to Medicare patients was Levothyroxine Sodium, with 960 prescriptions and refills. In total Lyle C Myers wrote 9,566 Medicare prescriptions that cost $4.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 960 | 2,472 | 291 | $13K |
| Metformin Hcl Generic | 422 | 1,125 | 135 | $3,154 |
| Ozempic Semaglutide | 390 | 526 | 85 | $477K |
| Mounjaro Tirzepatide | 332 | 389 | 79 | $404K |
| Jardiance Empagliflozin | 322 | 647 | 88 | $374K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 306 | 637 | 99 | $54K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 280 | 769 | 114 | $24K |
| Metformin Hcl Er Metformin Hcl | 267 | 762 | 96 | $2,883 |
| Glimepiride Generic | 232 | 597 | 80 | $1,981 |
| Soliqua 100-33 Insulin Glargine/Lixisenatide | 221 | 299 | 47 | $269K |
| Synthroid Levothyroxine Sodium | 194 | 459 | 53 | $12K |
| Trulicity Dulaglutide | 192 | 355 | 53 | $339K |
| Methimazole Generic | 176 | 451 | 56 | $1,770 |
| Farxiga Dapagliflozin Propanediol | 172 | 336 | 50 | $183K |
| Novolog Flexpen Insulin Aspart | 171 | 328 | 59 | $47K |
Brand drugs: 5,000 claims; generic drugs: 3,441 claims; opioid claims: 36.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lyle C Myers $459 ($459 in general payments such as food, travel and fees) from 12 companies. The largest payer was Medtronic, Inc. with $125.
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. MDT | 2 | $125 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $105 |
| Sanofi-Aventis U.S. LLC SNY | 3 | $57.5 |
| Merck Sharp & Dohme LLC MRK | 3 | $53.17 |
| Shionogi Inc 4507.T | 2 | $31.55 |
| Sequel Med Tech, LLC | 1 | $20.36 |
| Aimmune Therapeutics, Inc. | 1 | $17.07 |
| Neurocrine BioSciences, Inc. NBIX | 1 | $17.01 |
| Ascendis Pharma Endocrinology Inc ASND | 1 | $15.52 |
| Corcept Therapeutics CORT | 1 | $14.25 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.